Short interest for {{companyName}} gives investors a sense of the degree to which investors are betting on the decline of {{companyName}}'s stock. Short interest data is updated every two weeks.

Sirona Biochem Stock Short Interest Report | OTC:SRBCF | Benzinga

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.

News

Guidance

Contracts

Management

Global

SRBCF

Sirona Biochem Hires Investor Relations Firm Consulting to Increase Awareness in US

SIRONA BIOCHEM CORP ORD by Sirona Biochem Corp.

Sirona Biochem Corp

Press Releases

General

Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

Sirona Biochem Announces 2023 Annual Meeting Results

SIRONA BIOCHEM Corporate Update April 2024

Sirona Biochem Engages Stonegate Healthcare Partners

Health Care

Analyst Ratings

GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

TSXV:SBM

Sirona Biochem